Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - Loss AllowanceNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RedHill Biopharma (RDHL) Other Accumulated Expenses: 2011-2016

Historic Other Accumulated Expenses for RedHill Biopharma (RDHL) over the last 6 years, with Dec 2016 value amounting to $772,000.

  • RedHill Biopharma's Other Accumulated Expenses rose 8.27% to $772,000 in Q4 2016 from the same period last year, while for Dec 2016 it was $772,000, marking a year-over-year increase of 8.27%. This contributed to the annual value of $772,000 for FY2016, which is 8.27% up from last year.
  • Per RedHill Biopharma's latest filing, its Other Accumulated Expenses stood at $772,000 for FY2016, which was up 8.27% from $713,000 recorded in FY2015.
  • In the past 5 years, RedHill Biopharma's Other Accumulated Expenses registered a high of $772,000 during FY2016, and its lowest value of $300,000 during FY2012.
  • For the 3-year period, RedHill Biopharma's Other Accumulated Expenses averaged around $634,000, with its median value being $713,000 (2015).
  • Data for RedHill Biopharma's Other Accumulated Expenses shows a peak YoY skyrocketed of 70.98% (in 2015) over the last 5 years.
  • RedHill Biopharma's Other Accumulated Expenses (Yearly) stood at $300,000 in 2012, then increased by 21.00% to $363,000 in 2013, then rose by 14.88% to $417,000 in 2014, then spiked by 70.98% to $713,000 in 2015, then rose by 8.27% to $772,000 in 2016.